Pharmacological effects of serum containing Chinese medicine Bushen Huayu Jiedu compound recipe in lung cancer drug-resistance cells

Chinese Journal of Integrative Medicine

Volumn 14, Issue 1, 2008, Pages 46-50

  Cao, Yong ^a   Xia, Qing Hua ^a   Meng, Hua ^a   Zhong, An Pu ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

Ca2+ concentration; Cisplatin concentration; Lung cancer drug resistance cell; Lung drug resistance protein expression; Serum containing Chinese compound medicine

Indexed keywords

BUSHEN HUAYA JIEDU; CALCIUM ION; CHINESE DRUG; CISPLATIN; LRP 56 PROTEIN; MULTIDRUG RESISTANCE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CHINESE MEDICINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MEGADOSE; DRUG RESISTANCE; FEEDING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LOW DRUG DOSE; LUNG CANCER; MOUSE; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; STATISTICAL ANALYSIS;

ANIMALS; CALCIUM; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; HUMANS; LUNG NEOPLASMS; MEDICINE, CHINESE TRADITIONAL; MICE; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 41749117912     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11655-007-9004-4     Document Type: Article

References (8)

1. Oguri T, Isobe T, Suzuki T, et al. Increased expression MRP5 gene is associated with exposure to platinum drugs in lung cancer. Int J Cancer 2000;86:95-100.
2. Loe DW, Deeley RG, Cole SP. Biology of the multidrug resistance- associated protein, MRP. Eur J Cancer 1996;32A:945-957.
3. 2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression. Br J Cancer 1991;64:1011-1018.
4. 2+/calmoduln-dependent protein kinase II inhibitor, on adriamycin resistance of human ovarian cancer cells. Biochem Biophys Res Commun 1995;215:566-571.
5. Scheper RJ, Broxterman HJ, Scheffer GL, et al. Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res 1993;53:1475-1479.
6. Berger W, Elbing L, Micksche M, et al. Expression of the major vault protein LRP in human non-small-cell lung cancer cells activation by short-term exposure to antineoplastic drugs. Int J Cancer 2000;88:293-300.
7. Lu MJ, Wang J, Yi XH, et al. Clinical significance of the expression of lung resistance protein in non-small cell lung carcinomas. Chin J Tubercul Respir Dis (Chin) 2001; 24 (8):458-460.
8. Ikda K, Oka M, Narasaki F, et al. Lung resistance-related protein gene expression and drug sensitivity in human gastric and lung cancer cells. Anticancer Res 1998;18(4C):3077-3080.